Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominick J Angiolillo

Showing results (271-280 of 760) with videos related to

Pageof 76
Sort By:
Platelets|April 5, 2018
Systemic inflammatory status is associated with increased platelet reactivity in the early period after acute coronary syndromesStefano Cornara, Gabriele Crimi, Alberto Somaschini, et al.
Platelets|December 6, 2017
Cigarette smoking reduces platelet reactivity independently of clopidogrel treatment in patients with non-ST elevation acute coronary syndromesGabriele Crimi, Alberto Somaschini, Marco Cattaneo, et al.
Expert Review of Clinical Pharmacology|May 17, 2021
Genetic testing in patients undergoing percutaneous coronary intervention: rationale, evidence and practical recommendationsMattia Galli, Francesco Franchi, Fabiana Rollini, et al.
Thrombosis and Haemostasis|October 21, 2011
Platelet function profiles in the elderly: results of a pharmacodynamic study in patients on clopidogrel therapy and effects of switching to prasugrel 5 mg in patients with high platelet reactivityPiera Capranzano, Claudia Tamburino, Davide Capodanno, et al.
International Journal of Cardiology|March 12, 2026
Real-world adoption of the 2023 European Society of Cardiology guidelines regarding antiplatelet strategies in acute coronary syndromes: Insights from the European READAPT-2 surveyDominick J Angiolillo, David Erlinge, Chris P Gale, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|October 7, 2015
Platelet inhibition with ticagrelor versus clopidogrel in Hispanic patients with stable coronary artery disease with or without diabetes mellitusLeonardo C Clavijo, Juan Maya, Glenn Carlson, et al.
Lancet (London, England)|April 18, 2021
Guided versus standard antiplatelet therapy in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysisMattia Galli, Stefano Benenati, Davide Capodanno, et al.
Journal of Clinical Medicine|August 14, 2025
Antiplatelet Monotherapies for Long-Term Secondary Prevention Following Percutaneous Coronary InterventionClaudio Laudani, Daniele Giacoppo, Antonio Greco, et al.
Journal of the American Heart Association|December 8, 2020
Lipid Management in Patients Presenting With Acute Coronary Syndromes: A ReviewBimmer E Claessen, Paul Guedeney, C Michael Gibson, et al.
Journal of Thrombosis and Thrombolysis|February 22, 2020
Bioavailability of aspirin in fasted and fed states of a novel pharmaceutical lipid aspirin complex formulationDominick J Angiolillo, Deepak L Bhatt, Frank Lanza, et al.
Pageof 76

Showing results (271-280 of 760) with videos related to

Sort By:
Pageof 76
Platelets|April 5, 2018
Systemic inflammatory status is associated with increased platelet reactivity in the early period after acute coronary syndromesStefano Cornara, Gabriele Crimi, Alberto Somaschini, et al.
Platelets|December 6, 2017
Cigarette smoking reduces platelet reactivity independently of clopidogrel treatment in patients with non-ST elevation acute coronary syndromesGabriele Crimi, Alberto Somaschini, Marco Cattaneo, et al.
Expert Review of Clinical Pharmacology|May 17, 2021
Genetic testing in patients undergoing percutaneous coronary intervention: rationale, evidence and practical recommendationsMattia Galli, Francesco Franchi, Fabiana Rollini, et al.
Thrombosis and Haemostasis|October 21, 2011
Platelet function profiles in the elderly: results of a pharmacodynamic study in patients on clopidogrel therapy and effects of switching to prasugrel 5 mg in patients with high platelet reactivityPiera Capranzano, Claudia Tamburino, Davide Capodanno, et al.
International Journal of Cardiology|March 12, 2026
Real-world adoption of the 2023 European Society of Cardiology guidelines regarding antiplatelet strategies in acute coronary syndromes: Insights from the European READAPT-2 surveyDominick J Angiolillo, David Erlinge, Chris P Gale, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|October 7, 2015
Platelet inhibition with ticagrelor versus clopidogrel in Hispanic patients with stable coronary artery disease with or without diabetes mellitusLeonardo C Clavijo, Juan Maya, Glenn Carlson, et al.
Lancet (London, England)|April 18, 2021
Guided versus standard antiplatelet therapy in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysisMattia Galli, Stefano Benenati, Davide Capodanno, et al.
Journal of Clinical Medicine|August 14, 2025
Antiplatelet Monotherapies for Long-Term Secondary Prevention Following Percutaneous Coronary InterventionClaudio Laudani, Daniele Giacoppo, Antonio Greco, et al.
Journal of the American Heart Association|December 8, 2020
Lipid Management in Patients Presenting With Acute Coronary Syndromes: A ReviewBimmer E Claessen, Paul Guedeney, C Michael Gibson, et al.
Journal of Thrombosis and Thrombolysis|February 22, 2020
Bioavailability of aspirin in fasted and fed states of a novel pharmaceutical lipid aspirin complex formulationDominick J Angiolillo, Deepak L Bhatt, Frank Lanza, et al.
Pageof 76